Furosemide 40 MG Oral Tablet — RxCUI 313988
RxNorm drug concept · Semantic clinical drug
RxCUI 313988
Semantic clinical drug · SCD
● Current RxNorm concept 90 FDA products
246 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI313988
Official nameFurosemide 40 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped90
Package NDCs mapped246
Reported Medicaid activity (SDUD)2,730,358 prescriptions · 52 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Furosemide Injection: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Injectable furosemide is used when you need faster action than a pill can provide, or when you can't take oral medication — for example, in an emergency like acute pulmonary edema...
- Why am I getting this as an injection instead of a pill?
- The biggest things to watch for are signs of dehydration — feeling very dizzy, lightheaded, or faint, especially when you stand up — and muscle cramps or weakness, which can signal...
- What should I watch out for while using furosemide injection?
🕸️ Concept Web — How Furosemide 40 MG Oral Tablet Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Furosemide 40 MG Oral Tablet
RxCUI 313988 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Furosemide
4603IN
-
Furosemide
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Lasix
202991BN
-
Lasix
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Furosemide Oral Tablet
372281SCDF -
Furosemide Oral Product
1162714SCDG -
Furosemide Pill
1162715SCDG -
Furosemide Oral Tablet [Lasix]
368487SBDF -
Lasix Oral Product
1175647SBDG -
Lasix Pill
1175648SBDG -
Oral Tablet
317541DF -
Oral Product
1151131DFG - +1 more in this family
-
Furosemide Oral Tablet
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Furosemide 40 MG
315971SCDC -
Furosemide 40 MG Oral Tablet [Lasix]
200809SBD -
Furosemide 40 MG [Lasix]
565458SBDC
-
Furosemide 40 MG
Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Furosemide 40 MG
SCDC · 315971 -
Furosemide Oral Tablet
SCDF · 372281 -
Furosemide Oral Product
SCDG · 1162714 -
Furosemide Pill
SCDG · 1162715
Brand-Name Concepts
-
Furosemide 40 MG Oral Tablet [Lasix]
SBD · 200809 -
Furosemide 40 MG [Lasix]
SBDC · 565458 -
Furosemide Oral Tablet [Lasix]
SBDF · 368487 -
Lasix Oral Product
SBDG · 1175647 -
Lasix Pill
SBDG · 1175648 -
Lasix
BN · 202991
📦 FDA Products & Package NDCs
90 products · 246 package NDCs
246 package NDCs map to RxCUI 313988 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 51655-0269-26 | 90 TABLET in 1 BOTTLE, PLASTIC (51655-269-26) | FUROSEMIDE | Northwind Health Company, LLC | 2022-09-06 |
| 51655-0269-52 | 30 TABLET in 1 BOTTLE, PLASTIC (51655-269-52) | FUROSEMIDE | Northwind Health Company, LLC | 2022-08-08 |
| 51655-0269-53 | 10 TABLET in 1 BOTTLE, PLASTIC (51655-269-53) | FUROSEMIDE | Northwind Health Company, LLC | 2023-02-09 |
| 51655-0517-26 | 90 TABLET in 1 BOTTLE, PLASTIC (51655-517-26) | FUROSEMIDE | Northwind Health Company, LLC | 2022-07-11 |
| 51655-0517-52 | 30 TABLET in 1 BOTTLE, PLASTIC (51655-517-52) | FUROSEMIDE | Northwind Health Company, LLC | 2022-06-24 |
| 55154-2348-00 | 10 BLISTER PACK in 1 BAG (55154-2348-0) / 1 TABLET in 1 BLI... | Furosemide | Cardinal Health 107, LLC | 2024-12-04 |
| 55154-2349-00 | 10 BLISTER PACK in 1 BAG (55154-2349-0) / 1 TABLET in 1 BLI... | Furosemide | Cardinal Health 107, LLC | 2024-12-04 |
| 59651-0796-01 | 100 TABLET in 1 BOTTLE (59651-796-01) | FUROSEMIDE | Aurobindo Pharma Limited | 2025-07-17 |
| 59651-0796-99 | 1000 TABLET in 1 BOTTLE (59651-796-99) | FUROSEMIDE | Aurobindo Pharma Limited | 2025-07-17 |
| 59651-0797-01 | 100 TABLET in 1 BOTTLE (59651-797-01) | FUROSEMIDE | Aurobindo Pharma Limited | 2025-07-17 |
| 59651-0797-99 | 1000 TABLET in 1 BOTTLE (59651-797-99) | FUROSEMIDE | Aurobindo Pharma Limited | 2025-07-17 |
| 59651-0798-01 | 100 TABLET in 1 BOTTLE (59651-798-01) | FUROSEMIDE | Aurobindo Pharma Limited | 2025-07-17 |
| 59651-0798-05 | 500 TABLET in 1 BOTTLE (59651-798-05) | FUROSEMIDE | Aurobindo Pharma Limited | 2025-07-17 |
| 60760-0858-90 | 90 TABLET in 1 BOTTLE, PLASTIC (60760-858-90) | Furosemide | St. Mary's Medical Park Pharmacy | 2023-06-15 |
| 61919-0255-30 | 30 TABLET in 1 BOTTLE (61919-255-30) | Furosemide | Direct_Rx | 2021-10-21 |
| 61919-0255-90 | 90 TABLET in 1 BOTTLE (61919-255-90) | Furosemide | Direct_Rx | 2021-10-21 |
| 62135-0753-90 | 90 TABLET in 1 PACKAGE (62135-753-90) | Furosemide | Chartwell RX, LLC | 2024-04-17 |
| 62135-0754-90 | 90 TABLET in 1 PACKAGE (62135-754-90) | Furosemide | Chartwell RX, LLC | 2024-04-17 |
| 63187-0506-30 | 30 TABLET in 1 BOTTLE (63187-506-30) | Furosemide | Proficient Rx LP | 2018-12-01 |
| 63187-0506-60 | 60 TABLET in 1 BOTTLE (63187-506-60) | Furosemide | Proficient Rx LP | 2018-12-01 |
| 63187-0506-90 | 90 TABLET in 1 BOTTLE (63187-506-90) | Furosemide | Proficient Rx LP | 2018-12-01 |
| 63187-0517-30 | 30 TABLET in 1 BOTTLE (63187-517-30) | Furosemide | Proficient Rx LP | 2018-12-01 |
| 63187-0517-60 | 60 TABLET in 1 BOTTLE (63187-517-60) | Furosemide | Proficient Rx LP | 2018-12-01 |
| 63187-0517-90 | 90 TABLET in 1 BOTTLE (63187-517-90) | Furosemide | Proficient Rx LP | 2018-12-01 |
| 63187-0790-07 | 7 TABLET in 1 BOTTLE (63187-790-07) | Furosemide | Proficient Rx LP | 2025-07-18 |
| 63187-0790-30 | 30 TABLET in 1 BOTTLE (63187-790-30) | Furosemide | Proficient Rx LP | 2016-12-01 |
| 63187-0790-60 | 60 TABLET in 1 BOTTLE (63187-790-60) | Furosemide | Proficient Rx LP | 2016-12-01 |
| 63187-0790-90 | 90 TABLET in 1 BOTTLE (63187-790-90) | Furosemide | Proficient Rx LP | 2016-12-01 |
| 63561-0164-01 | 100 TABLET in 1 BOTTLE (63561-0164-1) | Furosemide | Granulation Technology, Inc. | 2026-01-15 |
| 63561-0164-02 | 1000 TABLET in 1 BOTTLE (63561-0164-2) | Furosemide | Granulation Technology, Inc. | 2025-12-18 |
| 63561-0164-09 | 90 TABLET in 1 BOTTLE (63561-0164-9) | Furosemide | Granulation Technology, Inc. | 2025-12-18 |
| 63561-0165-01 | 100 TABLET in 1 BOTTLE (63561-0165-1) | Furosemide | Granulation Technology, Inc. | 2026-01-15 |
| 63561-0165-02 | 1000 TABLET in 1 BOTTLE (63561-0165-2) | Furosemide | Granulation Technology, Inc. | 2025-12-18 |
| 63561-0165-09 | 90 TABLET in 1 BOTTLE (63561-0165-9) | Furosemide | Granulation Technology, Inc. | 2025-12-18 |
| 63561-0166-01 | 100 TABLET in 1 BOTTLE (63561-0166-1) | Furosemide | Granulation Technology, Inc. | 2026-01-15 |
| 63561-0166-05 | 500 TABLET in 1 BOTTLE (63561-0166-5) | Furosemide | Granulation Technology, Inc. | 2025-12-18 |
| 63561-0166-09 | 90 TABLET in 1 BOTTLE (63561-0166-9) | Furosemide | Granulation Technology, Inc. | 2025-12-18 |
| 63629-1216-01 | 100 TABLET in 1 BOTTLE (63629-1216-1) | Furosemide | Bryant Ranch Prepack | 2021-01-14 |
| 63629-1217-01 | 1000 TABLET in 1 BOTTLE (63629-1217-1) | Furosemide | Bryant Ranch Prepack | 2021-01-14 |
| 64980-0562-01 | 100 TABLET in 1 BOTTLE (64980-562-01) | Furosemide | Rising Pharma Holdings, Inc. | 2022-11-05 |
| 64980-0562-10 | 1000 TABLET in 1 BOTTLE (64980-562-10) | Furosemide | Rising Pharma Holdings, Inc. | 2022-11-05 |
| 64980-0563-01 | 100 TABLET in 1 BOTTLE (64980-563-01) | Furosemide | Rising Pharma Holdings, Inc. | 2022-11-05 |
| 64980-0563-10 | 1000 TABLET in 1 BOTTLE (64980-563-10) | Furosemide | Rising Pharma Holdings, Inc. | 2022-11-05 |
| 64980-0564-01 | 100 TABLET in 1 BOTTLE (64980-564-01) | Furosemide | Rising Pharma Holdings, Inc. | 2022-11-05 |
| 64980-0564-50 | 500 TABLET in 1 BOTTLE (64980-564-50) | Furosemide | Rising Pharma Holdings, Inc. | 2022-11-05 |
| 67046-1663-03 | 30 TABLET in 1 BLISTER PACK (67046-1663-3) | Furosemide | Coupler LLC | 2026-03-11 |
| 67296-2139-03 | 30 TABLET in 1 BOTTLE (67296-2139-3) | Furosemide | Redpharm Drug | 2022-11-05 |
| 68071-1809-01 | 100 TABLET in 1 BOTTLE (68071-1809-1) | Furosemide | NuCare Pharmaceuticals,Inc. | 2019-01-29 |
| 68071-2360-01 | 100 TABLET in 1 BOTTLE, PLASTIC (68071-2360-1) | Furosemide | NuCare Pharmaceuticals,Inc. | 2021-03-11 |
| 68071-3273-03 | 30 TABLET in 1 BOTTLE (68071-3273-3) | Furosemide | NuCare Pharmaceuticals,Inc. | 2019-01-29 |
Observed labelers:
Aphena Pharma Solutions - Tennessee, LLC (37) ·
Bryant Ranch Prepack (31) ·
A-S Medication Solutions (19) ·
NuCare Pharmaceuticals,Inc. (14) ·
NCS HealthCare of KY, LLC dba Vangard Labs (13) ·
Hikma Pharmaceuticals USA Inc. (12)
· +24 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.